Blockbuster Management
Forecast 2007: At Sea
The new year started early for pharma—and with a bang. Hard on the Democratic win in the midterm elections came the industry leader's week from hell
Date:
01/01/2007
, Publication:
Pharmaceutical Executive
, Author:
Walter Armstrong
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=395602
Sales Slip
Even before Pfizer blinked, companies were asking, What ails sales? In this annual survey,
Date:
01/01/2007
, Publication:
Pharmaceutical Executive
, Author:
Bob Davenport , Carrie Fisher , Erin Rosner
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=395596
Eisai award recognizes R.Ph.s' role in Alzheimer's care
For five years now, Eisai, maker of Aricept (donepezil HCl), has offered an annual recognition award
Date:
11/20/2006
, Publication:
Drug Topics
, Author:
Staff
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=385549
What Type of Brand Are You?
Stop the aimless soul searching. The path to brand success lies in understanding how best to position your drug.
Date:
06/01/2006
, Publication:
Pharmaceutical Executive
, Author:
Vince Parry
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=333312
2005 Rx Market: The highs and lows
Lack of blockbuster launches makes for uneventful year; still, scripts rise 3%...
Date:
03/20/2006
, Publication:
Drug Topics
, Author:
Fred Gebhart
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=312505
Cigna hopes to involve R.Ph.s in diabetes project
A program using claims and refills data to identify diabetes patients...
Date:
02/06/2006
, Publication:
Drug Topics
, Author:
Martin Sipkoff
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=302233
Introduction: Opportunites and Challenges
Blockbuster drugs that represent 50 to 60 percent of pharmaceutical sales will come off patent in the next few years...
Date:
02/01/2006
, Publication:
Pharmaceutical Executive
, Author:
Jeannette Park
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=285291
SECOND OPINION: Generalist physicians т€Â&8220; added value in a crisis
This month, I'm sharing this space with a colleague on the Patient Care Board of Editors...
Date:
11/01/2005
, Publication:
Patient Care
, Author:
R. Whit Curry, MD
http://www.patientcareonline.com/patcare/article/articleDetail.jsp?id=197805
Generic Pharma Battles for Allegra Rights
Rival generic drug makers have struck a deal to create a competitive edge in what has become an overly...
Date:
10/01/2005
, Publication:
Pharmacy Times - GPR
, Author:
Michelle Whelan
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=2754
Building Blockbusters
The most lucrative new drugs are often less glamorous than first-in-class NMEs. And they are much less risky.
Date:
09/01/2005
, Publication:
Pharmaceutical Executive
, Author:
Michael G. Parker, David Amar
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=177965
< Previous
Page 2 of 4
Next >
Search returned 32 items.
|
Sponsored Links
Reach these Drug Developers
Via Email or Mail List Rentals
www.biotechmedia.com
Medical Marketing & Media is a monthly
to 14,000 healthcare marketing executives
www.medicalmarketingandmedia.com
Smart strategic thinking and
innovative creative execution
www.adwise.com
|